Xtant Medical Holdings, Inc. (XTNT) P/E Ratio History
Deep ValueTrading at 12.5x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2023–2026
Loading P/E history...
P/E Ratio Analysis
As of September 24, 2026, Xtant Medical Holdings, Inc. (XTNT) trades at a price-to-earnings ratio of 12.5x, with a stock price of $0.38 and trailing twelve-month earnings per share of $-0.08.
The current P/E is 81% below its 5-year average of 65.0x. Over the past five years, XTNT's P/E has ranged from a low of 23.4x to a high of 129.4x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.7x, XTNT trades at a 47% discount to its sector peers. The sector includes 225 companies with P/E ratios ranging from 0.0x to 167.0x.
Relative to the broader market, XTNT trades at a notable discount to the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our XTNT DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
XTNT Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
XTNT P/E vs Peers
Orthopedics, spine, and sports medicine peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $668M | 9.5Lowest | - | +30% | |
| $10B | 18.9 | 0.61Best | +423%Best | |
| $3B | 23.3 | 1.41 | +18% | |
| $18B | 25.6 | - | -20% | |
| $105B | 32.5 | 2.19 | +8% | |
| $115B | 23.9 | 3.42 | +3% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
XTNT Historical P/E Data (2023–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $0.56 | $0.01 | 44.3x | -32% |
| FY2025 Q4 | Dec 31 2025 | $0.78 | $0.03 | 23.4x | -64% |
| FY2025 Q3 | - | $0.65 | $0.01 | 63.0x | -3% |
| FY2023 Q3 | Sep 30 2023 | $1.10 | $0.01 | 129.4x | +99% |
Average P/E for displayed period: 65.0x
XTNT Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
3+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
XTNT — Frequently Asked Questions
Quick answers to the most common questions about buying XTNT stock.
What is XTNT's P/E ratio?
Xtant Medical Holdings, Inc. (XTNT) trailing twelve-month P/E ratio is 12.5x, based on TTM diluted EPS of $-0.08. The 5-year average P/E is 65.0x and the historical range spans 23.4x to 129.4x.
Is XTNT stock overvalued or undervalued?
XTNT trades at 12.5x P/E, below its 5-year average of 65.0x. At the 0th percentile of its historical range (23.4x–129.4x), the stock is priced at a discount to its own history.
Is XTNT stock expensive?
No, XTNT is not expensive on a historical basis. The current P/E of 12.5x is below the 5-year average of 65.0x and sits at the 0th percentile of its valuation range.
What is XTNT's historical P/E range?
Over the past 5 years, XTNT's P/E ratio has ranged from 23.4x to 129.4x, with a median of 63.0x and an average of 65.0x. The current P/E of 12.5x places the stock at the 0th percentile of this range. Full historical data spans 2023–2026.
How does XTNT's P/E compare to the S&P 500?
XTNT trades at 12.5x P/E versus the S&P 500 median of 25.3x. The 51% discount to the market suggests lower growth expectations or perceived higher risk.
How does XTNT's valuation compare to Healthcare peers?
Xtant Medical Holdings, Inc. P/E of 12.5x compares to the Healthcare sector median of 23.7x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is XTNT's PEG ratio?
XTNT PEG ratio is N/A, based on a P/E of 12.5x and EPS growth of 125.0%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is XTNT's earnings yield?
XTNT earnings yield is 8.00%, the inverse of its 12.5x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.